FH and neoplasm: FH alterations seem to be enriched in tumours with aggressive histopathologic features or aggressive clinical behaviour, suggesting that loss of FH expression could be a useful prognostic marker in primary tumours with adverse histopathologic findings (Figure 2A,B).23